Current Drug Targets - Infectious Disorders

Developments in Antiviral Drug Design, Discovery and Development in 2004

Pp: 307-400
Author(s): Nicholas A. Meanwell, Makonen Belema, David J. Carini, Stanley V. D'Andrea, John F. Kadow, Mark Krystal, B. N. Naidu, Alicia Regueiro-Ren, Paul M. Scola, Sing-Yuen Sit, Michael A. Walker, Tao Wang and Kap-Sun Yeung
DOI: 10.2174/156800505774912893

Cite

Neuraminidase Inhibitors as Antiviral Agents

Pp: 401-409
Author(s): I. V. Alymova, G. Taylor and A. Portner
DOI: 10.2174/156800505774912884

Cite

Chemosensitizers in Drug Transport Mechanisms Involved in Protozoan Resistance

Pp: 411-431
Author(s): Bruno Pradines, Jean-Marie Pages and Jacques Barbe
DOI: 10.2174/156800505774912875

Cite

Discoveries of Tat-TAR Interaction Inhibitors for HIV-1

Pp: 433-444
Author(s): Ming Yang
DOI: 10.2174/156800505774912901

Cite

Current Drug Targets - Infectious Disorders

Volume 5, Issue 4 , 2005

Developments in Antiviral Drug Design, Discovery and Development in 2004

Neuraminidase Inhibitors as Antiviral Agents

Chemosensitizers in Drug Transport Mechanisms Involved in Protozoan Resistance

Discoveries of Tat-TAR Interaction Inhibitors for HIV-1